Abstract
Viral diseases, from common respiratory infections to serious illnesses such as AIDS, pose public health challenges. The use of antiretrovirals is essential to contain these diseases, offering a better quality of life to patients. Protease inhibitors (PIs) are a class of antiretrovirals used to treat HIV, but they have disadvantages such as low bioavailability, which requires administrati…